Veterinary Medicines

Salmoporc, lyophilisate and solvent for suspension for injection / lyophilisate for use in drinking water

Authorised
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, histidine-adenine auxotrophic, Live
Download as PDF

Product identification

Medicine name:
Salmoporc, lyophilisate and solvent for suspension for injection / lyophilisate for use in drinking water
Salmoporc, Lyophilisat und Lösungsmittel zur Herstellung einer Suspension zur Injektion / Lyophilisat zur Anwendung mit Trinkwasser
Active substance:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, histidine-adenine auxotrophic, Live
Target species:
  • Pig
  • Pig (sow for reproduction)
  • Pig (sucking piglet)
Route of administration:
  • Subcutaneous use
  • Oral use

Product details

Active substance and strength:
  • Salmonella enterica, subsp. enterica, serovar Typhimurium, histidine-adenine auxotrophic, Live
    5000.00
    million colony forming units
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig
      • Meat and offal
        6
        week
    • Pig (sow for reproduction)
      • Meat and offal
        6
        week
  • Oral use
    • Pig (sucking piglet)
      • Meat and offal
        6
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AE02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID2): Cardboard box containing 1 vial with 200 doses
  • (ID1): Cardboard box containing 1 vial with 20 doses lyophilised vaccine and 1 vial with 20 ml solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Tiergesundheit GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Veterinary Biologicals Co. Ltd.
  • IDT Biologika GmbH
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.02340.01.1
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0290/001
Concerned member states:
  • France
  • Spain
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."